BMRN (BMRN) Stock Price & Analysis
BMRN (BMRN) rose 0.15% to USD 66.53 as of September 8, 2026 at 04:20 UTC, according to Nexqual real-time market data.
BMRN last closed at USD 66.53; the session ranged USD 65.52–66.64 on volume of 2,299,208 shares. Market capitalization is —, with a 52-week range of USD 49.26–70.98 (NMS). Source: Nexqual, September 8, 2026 at 04:20 UTC.
Key Statistics (as of September 8, 2026 at 04:20 UTC)
| Price | USD 66.53 |
|---|---|
| Change | ▲ 0.15% (up) |
| Previous Close | USD 66.53 |
| Open | USD 66.53 |
| Day Range | USD 65.52 – 66.64 |
| 52-Week Range | USD 49.26 – 70.98 |
| Volume | 2,299,208 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BMRN)
Nexqual's technical model rates BMRN "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 04:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.73 (neutral) |
| vs SMA50 | Above (USD 62.58) |
| MACD | 0.95 (positive) |
From BMRN's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INCY | Incyte Corporation | USD 126.75 | ▼ 1.61% |
| ALNY | Alnylam Pharmaceuticals, Inc. | USD 266.11 | ▼ 0.48% |
| VRTX | Vertex Pharmaceuticals Incorpor | USD 546.12 | ▼ 1.91% |
| REGN | Regeneron Pharmaceuticals, Inc. | USD 827.72 | ▼ 2.85% |
| BIIB | Biogen Inc. | USD 220.83 | ▼ 0.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:20 UTC. This page is informational and not investment advice.